Tapping the $50B Consumer Spend Where Nutrition and Sleep Intersect, Nightfood (OTCQB: NGTF) Pioneers New Snack Category

Tapping the $50B Consumer Spend Where Nutrition and Sleep Intersect, Nightfood (OTCQB: NGTF) Pioneers New Snack Category Nightfood Ice Cream is Available in over 1,500 Supermarkets, Including Walmart Regions, Divisions of Albertson’s and HEB, and Hundreds of Independent Grocery Stores. – Net Revenue Growth Over 190% Year-Over-Year – National Hotel Rollout Expected – Category Interest from Pepsi, Unilever, and Nestle Americans spend over $50 billion… Read More »Tapping the $50B Consumer Spend Where Nutrition and Sleep Intersect, Nightfood (OTCQB: NGTF) Pioneers New Snack Category

NASDAQ Company Completes Acquisition of High Performance Computer Provider Lyte Technology. Revenue Guidance for 2021 4th Quarter Expected to Exceed $5M: Phunware, Inc (NASDAQ: PHUN)

NASDAQ Company Completes Acquisition of High Performance Computer Provider Lyte Technology. Revenue Guidance for 2021 4th Quarter Expected to Exceed $5M: Phunware, Inc (NASDAQ: PHUN) PHUN is Everything You Need to Succeed on your Mobile. Software that exhibits gamelike mechanics and behavior so brands can contextually engage customers and drive digital transformation Breaking News:b AUSTIN, Texas, Oct. 19, 2021 (Viz Release) — Phunware, Inc. (NASDAQ:… Read More »NASDAQ Company Completes Acquisition of High Performance Computer Provider Lyte Technology. Revenue Guidance for 2021 4th Quarter Expected to Exceed $5M: Phunware, Inc (NASDAQ: PHUN)

NASDAQ Company Announces 1st Patient Dosing for Placebo Controlled Trial of JW-300. Treatment of First Degree Burns: Jupiter Wellness, Inc. (NASDAQ: JUPW)

NASDAQ Company Announces 1st Patient Dosing for Placebo Controlled Trial of JW-300. Treatment of First Degree Burns: Jupiter Wellness, Inc. (NASDAQ: JUPW) Breaking News: JUPITER, FL / October 19th, 2021 / Jupiter Wellness, Inc. (NASDAQ:JUPW), a clinical stage company developing a cannabinoid receptor agonist for the treatment of first degree burns, announced the enrollment and dosing of the first patient in the study. The double-blinded placebo-controlled study… Read More »NASDAQ Company Announces 1st Patient Dosing for Placebo Controlled Trial of JW-300. Treatment of First Degree Burns: Jupiter Wellness, Inc. (NASDAQ: JUPW)

Multidisciplinary Nasdaq Listed Healthcare Provider Growing via Multiple High Value Acquisitions: Novo Integrated Sciences, Inc. (NASDAQ: NVOS)

Multidisciplinary Nasdaq Listed Healthcare Provider Growing via Multiple High Value Acquisitions: Novo Integrated Sciences, Inc. (NASDAQ: NVOS) – Holistic Approach to Patient-First Health and Wellness Care. – LOIs Signed to Acquire Seven Pharmacies in the US Which Collectively Generated Approximately $55 Million Annualized Sales in 2020. – Contemplated All-Stock Transactions Would Establish a Footprint in the US to Leverage Multidisciplinary Healthcare Products and Services. –… Read More »Multidisciplinary Nasdaq Listed Healthcare Provider Growing via Multiple High Value Acquisitions: Novo Integrated Sciences, Inc. (NASDAQ: NVOS)

This NASDAQ has Life Saving Advances in Today’s Most Critical Bio-Science Fields of Cancer and Immune Related Disease, Including COVID-19: Avalon GloboCare Corp. (NASDAQ: AVCO)

This NASDAQ has Life Saving Advances in Today’s Most Critical Bio-Science Fields of Cancer & Immune Related Disease, Including COVID-19: Avalon GloboCare Corp. (NASDAQ: AVCO) – Clinical-Stage CellTech Developer Dedicated to Immune Effector Cell Therapy and Exosome Technology. – Introducing Life Saving COVID-19 Diagnostics and Therapeutics. – New Treatment for Deadly Cytokine Storm in COVID-19 Patients. – Novel Technology to Efficiently Synthesize & Study Previously… Read More »This NASDAQ has Life Saving Advances in Today’s Most Critical Bio-Science Fields of Cancer and Immune Related Disease, Including COVID-19: Avalon GloboCare Corp. (NASDAQ: AVCO)

Fueled By Innovation, IronOrbit Introduces Advanced Service Offerings

Tuesday, October 12, 2021 – Anaheim Hills, CA – cloud service provider and technology innovator, IronOrbit announced the general availability of an advanced suite of managed services, robust security offerings, automation, and professional services. The newly launched suite of services aims to equip customers with the tools needed to empower, optimize, and secure business critical operations for efficiency, self-service, and success. In the spirit of… Read More »Fueled By Innovation, IronOrbit Introduces Advanced Service Offerings

NASDAQ company Focuses on Female Oriented Healthcare Advances with Focus on Permanent Birth Control and Infertility, Clinical Trials Underway: Femasys (NASDAQ: FEMY)

Female Oriented Healthcare Advances with Focus on Permanent Birth Control and Infertility, Clinical Trials Underway: Femasys (NASDAQ: FEMY) – Commitment and Company Focus on Transforming Women’s Healthcare. – Completed Initial Public Offering Raising Net Proceeds of $31.6 Million. – Intellectual Property Portfolio with Over 100 Patents Globally. – Developing Advanced Treatments for Permanent Birth Control & Infertility. – Medical Industry Veteran Edward Evantash, M.D. as… Read More »NASDAQ company Focuses on Female Oriented Healthcare Advances with Focus on Permanent Birth Control and Infertility, Clinical Trials Underway: Femasys (NASDAQ: FEMY)